ODC1 and human African trypanosomiasis: After the initial success in the early 1980s with DFMO as an irreversible ODC inhibitor against African trypanosomiasis, enthusiasm for finding new and better inhibitors of polyamine synthesis as a drug target for trypanosomatid diseases has diminished considerably.